Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EverCore Tablets is a prescription-strength multivitamin and multimineral supplement developed and marketed by Blue Heron Pharmaceuticals. The formulation is specifically designed to provide high-potency nutritional support, containing a combination of Vitamin D3 (cholecalciferol), Vitamin B6 (pyridoxine), Vitamin B12 (cyanocobalamin), and Folic Acid. It is primarily indicated for the dietary management of patients with nutritional deficiencies or those requiring supplemental vitamins due to specific medical conditions such as hyperhomocysteinemia. The product is administered orally and is part of Blue Heron's portfolio of specialized vitamin and mineral supplements, often used in prenatal or general nutritional care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on EverCore Tablets.